WHO European health information at your fingertips.

Indicator is part of data set(s):

HFA-DB

Indicator full name: Crude death rate per 1000 population, females

Unit: deaths per 1000 population

Dimensions:

Country/Area (COUNTRY/AREA)
Supranational group of countries (COUNTRY_GRP)
Sex (SEX)
Year of measure (YEAR)

Years data is available: 1968—2020

Last updated: 21 October 2025

Export to:

HFA-DB

European Health for All database

Indicators: 618

Updated: 21 October 2025

Contact: Data, Artificial Intelligence and Digital Health unit (DAD)

The following abbreviations are used in the indicator titles:

• SDR: age-standardized death rates (see HFA-DB user manual/Technical notes, page 13, for details)

• FTE: full-time equivalent

• PP: physical persons

• PPP$: purchasing power parities expressed in US $, an internationally comparable scale reflecting the relative domestic purchasing powers of currencies.

Indicator notes

Crude death rate per 1000 population, females
Indicator code: E998005.F This indicator shares the definition with the parent indicator \"Crude death rate per 1000 population\".

A simple ratio of a number of deaths registered during the year and the mid-year population for the same year, multiplied by 1000. The crude death rate (CDR) normally should not be used for international comparisons as it strongly depends on the age structure of the populations being compared and may be misleading. For example, CDR for a developing country generally is lower than the CDR for a developed country, due purely to different population structures, i.e. older population in the developed country.

For international comparisons the age-standardized death rates (SDRs) are preferable._

Country/Area notes

Türkiye

Source: TURKSTAT (Turkish Statistical Institute).
From 1990 to 2007, data are based on mid-year estimations of national population projections.
Between 2008 and 2011 data are based on administrative data.

General notes

Understanding the Crude Death Rate per 1000 Population for Females

The crude death rate (CDR) for females is a vital demographic indicator that helps us understand the overall health and mortality trends within a female population. This rate, calculated per 1000 females, provides insights into the number of deaths occurring during a given year. It serves as a fundamental measure for public health officials, policymakers, and researchers to assess the impact of health policies, access to medical care, and other socio-economic factors affecting women's health across different regions and countries.

The Significance of the Crude Death Rate for Females

The crude death rate for females is not just a number but a reflection of the broader health environment that women experience in a society. It highlights the effectiveness of healthcare systems, the prevalence of diseases, and the impact of public health initiatives aimed at improving women's health. Moreover, this rate assists in identifying vulnerable groups who may be at higher risk, guiding targeted interventions and resource allocation to areas most in need. Understanding these trends is essential for advancing gender-specific health policies and promoting equitable health outcomes for women globally.

Strengths and Limitations of the Crude Death Rate for Females

The crude death rate for females, while a critical indicator, comes with its own set of strengths and limitations that influence its utility and interpretation.

Strengths

This rate is universally recognized and standardized, making it a reliable metric for international health comparisons and trend analysis over time. It is instrumental in evaluating the success of health interventions and identifying shifts in health patterns among the female population. Additionally, the CDR provides a clear, quantifiable measure that can influence policy decisions and health planning, ensuring resources are appropriately directed towards improving women's health outcomes.

Limitations

However, the crude death rate does not account for the age structure of the population, which can vary significantly between different regions and affect mortality rates. This limitation can lead to misleading interpretations if not considered alongside age-specific death rates. Furthermore, the accuracy of the CDR heavily depends on the quality of data on female deaths and population estimates. In regions where data collection is inconsistent or incomplete, the reliability of the crude death rate can be compromised, potentially leading to inadequate health responses. Additionally, the CDR does not provide insights into the causes of death, which are crucial for developing targeted health interventions.

In conclusion, while the crude death rate per 1000 population for females is an essential health indicator, it must be analyzed in conjunction with other demographic and health data to fully understand and effectively address the health challenges faced by women.